- Home
- DOCS vs MEDP Comparison
DOCS vs MEDP Comparison
Compare DOCS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- MEDP
- Stock Information
- Founded
- DOCS 2010
- MEDP 1992
- Country
- DOCS United States
- MEDP United States
- Employees
- DOCS N/A
- MEDP N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DOCS Technology
- MEDP Health Care
- Exchange
- DOCS Nasdaq
- MEDP Nasdaq
- Market Cap
- DOCS 13.7B
- MEDP 13.4B
- IPO Year
- DOCS 2021
- MEDP 2016
- Fundamental
- Price
- DOCS $71.11
- MEDP $528.48
- Analyst Decision
- DOCS Buy
- MEDP Hold
- Analyst Count
- DOCS 19
- MEDP 11
- Target Price
- DOCS $68.68
- MEDP $421.60
- AVG Volume (30 Days)
- DOCS 1.4M
- MEDP 297.2K
- Earning Date
- DOCS 11-06-2025
- MEDP 10-22-2025
- Dividend Yield
- DOCS N/A
- MEDP N/A
- EPS Growth
- DOCS 45.79
- MEDP 26.42
- EPS
- DOCS 1.17
- MEDP 13.46
- Revenue
- DOCS $589,636,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- DOCS $13.33
- MEDP $19.06
- Revenue Next Year
- DOCS $10.90
- MEDP $8.64
- P/E Ratio
- DOCS $60.92
- MEDP $39.18
- Revenue Growth
- DOCS 19.45
- MEDP 9.94
- 52 Week Low
- DOCS $40.87
- MEDP $250.05
- 52 Week High
- DOCS $85.21
- MEDP $547.15
- Technical
- Relative Strength Index (RSI)
- DOCS 49.49
- MEDP 68.69
- Support Level
- DOCS $69.16
- MEDP $484.00
- Resistance Level
- DOCS $74.33
- MEDP $547.15
- Average True Range (ATR)
- DOCS 2.20
- MEDP 13.13
- MACD
- DOCS -0.55
- MEDP 0.92
- Stochastic Oscillator
- DOCS 23.88
- MEDP 71.08
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.